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Abstract 
Wagner, Jessica Ann.  M.S., Department of Neuroscience, Cell Biology, and Physiology, 
Wright State University, 2014. 
Effects of Transcranial Direct Current Stimulation on Expression of Immediate Early 
Genes (IEG’s) 
 
 Transcranial direct current stimulation (tDCS) has been utilized in human studies 
to modulate a multitude of psychological, cognitive, and psychiatric disorders5. There   
have been positive behavioral results in human subjects1, 2, 3, but our knowledge of 
biological processes occurring during stimulation to elicit behavioral outcomes is limited. 
Our study utilizes a rodent tDCS (R-tDCS) model in which Sprague Dawley rats receive 
tDCS in order to examine whether tDCS affects neuronal activation. We examined two 
immediate early genes (IEG’s), cFos and zif268, in order to discern if tDCS affects 
neuronal activation. Our findings indicate that tDCS does affect neuronal activation by 
means of IEG induction and that there is dose dependence between current intensity used 
and mRNA levels of IEG’s. These findings are important because they show biologically 
tDCS affecting neuronal activation. This study aided the scientific community in better 
understanding what is occurring biologically during tDCS.
iii 
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 Transcranial Direct Current Stimulation (tDCS) is a novel non-invasive brain 
stimulation (NIBS) procedure that has shown evidence of enhancing cognitive 
capabilities in human subjects1, 2, and 3. Studies have also shown tDCS can produce 
positive outcomes in treating depression, addiction, anxiety disorders, pain, and 
schizophrenia5.   tDCS is a protocol involving sub threshold current flowing across the 
scalp, which can penetrate the skull and current flows across brain. Being a sub threshold 
current, it does not elicit an action potential event, but may modulate the firing rate of 
existing signaling pathways4. There are two types of tDCS stimulations: anodal, or 
negative current, and cathodal, or positive current. Anodal stimulation conventionally is 
excitable, while cathodal diminishes this effect4. tDCS can induce excitability in the 
human motor cortex upon anodal tDCS treatment and this excitability can be abolished 
with an NMDA receptor antagonist4. These results indicate that anodal tDCS treatment is 
dependent upon NMDA activity. This indicates that tDCS is a NMDA dependent 
treatment, and to further investigate what occurs biologically we want to examine NMDA 
dependent pathways. 
 Recent studies show a positive correlation between tDCS treatment and 
enhancement of cognitive performance1, 2, and 3. Although behavioral outcomes are of 
interest, we need to determine which biological processes are modulated before moving 
forward with tDCS. The studies to report cognitive enhancement were conducted in 
humans, limiting what can be analyzed molecularly at this point, and we propose a rodent 
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tDCS (R-tDCS) model that will aid in the understanding of biological pathways involved 
with tDCS. It is apparent from human studies tDCS after-effects are dependent upon the 
NMDA receptor activity4.  These after-effects of tDCS are thought to result from 
modulation of neuronal activity6, 7, and 8. tDCS is thought to affect neuronal activation, 
therefore we are studying whether tDCS modulates neuronal activity via immediate early 
genes IEG’s (Immediate Early Genes): cFos and zif268.  
 Other brain stimulation techniques have looked at IEG transcript changes, but 
none due to tDCS. Experiments in TMS (transcranial magnetic stimulation) show 
differential expression of zif268 and cFos due to stimulation9. Both genes responded to 
stimulation, but to different stimulation parameters. Another study focused on cFos and 
zif268 in response to direct current stimulation (DCS) in rat hippocampal slices which, 
showed responses of both genes in the hippocampus10. Histological studies have been 
conducted in rodent models of tDCS, show that increasing current intensity will increase 
the probability of stimulation producing lesions11. We are examining biological effects to 
increases in current intensity which has not been shown prior to this study. These studies 
show positive induction of cFos and zif268, which we hypothesized, would also respond 
to tDCS treatment. So far, neither cFos nor zif268 have been examined following tDCS 
treatment at varying current intensities. 
 
Neuronal Activation: 
 Since the beginning of tDCS research, studies have investigated whether tDCS 
modulates neuronal activity. tDCS has been shown to modulate neuronal firing12 and 
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amplitude of evoked action potentials8 . These results were obtained using 
electrophysiological experiments, and we plan to answer this question by examining 
biological markers of neuronal activation. The polarizing current of tDCS is thought to 
modulate neuronal activity by changing the membrane potential and increasing the 
stochastic firing rate of neurons13. We plan to investigate the relationship between tDCS 
and neuronal activation by examining two IEG’s cFos and zif268. IEG’s are known to be 
some of the first genes transcribed during activation, so they are the ideal candidates to 
investigate this question. The IEG’s become induced in response to secondary 
messengers activating kinases. Once the IEG’s are transcribed and translated into DNA, 
they can re-enter the nucleus and cause the induction of novel gene transcription (Figure 
1).  As stated earlier, there has been research with electrophysiological experiments, but 
we think it is also important to measure the biological markers that are being activated in 
order to fully understand the biological processes occurring. We hope to gain information 
about tDCS that we are unable to obtain in human subjects.  
 cFos and zif268 have been modulated by other activation evoking stimuli, so we 
believe if tDCS does modulate neuronal activation we will be able to capture this with the 
induction of IEG’s. By measuring the transcript expression levels of cFos and zif268 we 
will be able to discern which areas are being activated, and hopefully be able to follow 
the current path into the brain.  
Immediate Early Genes: 
 IEG’s are recognized as genes that are transiently transcribed and independent of  
de novo protein synthesis to be transcribed14. IEG induction occurs with an array of 
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stimuli, indicating that they part of the first wave of genetic responses15, 16. There are two 
types of IEG subclasses: regulatory transcription factors and effectors. The regulatory 
transcription factors (RTFs) act as transcription factors to downstream elements involved 
in modifying the phenotype of the cell15, 16. Once translated, these proteins can re-enter 
the nucleus and up-regulate the transcription of de novo downstream elements (Figure 1). 
Since the nature of IEG genes is to respond rapidly, we anticipate following tDCS 
treatment we will see modulation in mRNA levels of these genes. The transcription of 
IEGs, mainly RTFs, in early phases of cellular activation is thought to contribute to 
transcriptional changes seen in subsequent phases17. The IEG’s we examined are RTF’s, 
which can rapidly recruit transcription apparatuses to promoter sites of target genes18. 
Zif268 and cFos are highlighted because they belong in the RTF subclass of IEG’s, 
meaning they are the first wave of genetic transcription. The IEG’s, cFos and zif268, are 
ideal candidates to study how tDCS affects neuronal activation.  
 
4 







Zif268 is an IEG which encodes a zinc finger protein that acts as a transcription factor. 
The gene plays a crucial role in LTP (Long-Term Potentiation), mainly the transition 
between early and late phase LTP17. Without the expression of zif268 the long term 
memory consolidation of the individual diminishes, thus demonstrating the role of this 
gene for LTP maintenance17. We are studying this gene since it produces a robust and 
rapid response to LTP inducible stimuli19 and has been shown to respond under the 
behavioral environment in which tDCS is administered20. Zif268 has also shown a 
dependence on NMDA activity and highly correlated with LTP events32. This IEG is of 
Figure 1: Schematic of IEG induction. An extracellular molecule 
interacts with a cell surface receptor which can trigger secondary 
messengers to begin the pathway. IEG’s can enter the nucleus, bind to 
DNA and induce novel gene transcription.  The early phase requires 
responses from protein kinases, while the late response requires 
transcriptional changes. 
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interest because of its dependence on NMDA, since tDCS studies in humans have shown 
a dependence of after-effects with NMDA activation. 
cFos:  
cFos is part of a protein family that forms complexes with Jun, which constitute the 
activator protein (AP-1)21. cFos is an IEG that has shown up-regulation due to a 
multitude of stimuli22, examples including: activation in olfactory bulbs due to scent23, 
expression in striatum due to caffeine intake26, and activation in auditory cortex due to 
auditory cues27. cFos is able to auto-regulate itself, by a negative feedback loop15. 
Research shows that in the presence of protein synthesis inhibitors, cFos expression is 
super induced, indicating the de novo protein synthesis is needed to shut off cFos 
expression15. cFos is also an ideal marker for neuronal activation, in which its expression 
increases in brain regions when exposed to associated stimuli23. Also, cFos is unique 
from other IEG’s in that its basal levels are relatively low, there is a broad range of 
mRNA levels, and both mRNA and protein have a short half-life24. This aspect of cFos 
makes it easier to capture, since there is such a broad range of transcript levels 
researchers can observe changes. 
Current Intensity 
 In our animal model we wanted to determine the effects of varying current 
intensities with the expression of cFos and zif268. With varying current, from highest 
setting (2,500 µA) to our awake stimulation current (75 µA), we want to determine 
changes of zif268 and cFos expression in terms of transcription levels and with zif268 
protein expression. Studies have been performed to determine safety levels of tDCS in 
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rodents11. While the Liebtanz study concentrates on lesion size occurring at high current 
intensities; we want to focus on genetic changes occurring at these intensity levels. 
Liebtanz’ s study was important since it was the first to evaluate tDCS current safety 
levels in rodents, giving researchers a better range of current intensities to utilize. 
Researchers have shown evidence indicating that the current dosage effects may 
not be a linear relationship25. This study showed that above a threshold value, in their 
study 2,000 µA, the effects seen were opposite of what is expected; at 2,000 µA cathodal 
current induced excitation, instead of the expected inhibition25. Being able to describe 
biologically this relationship between current intensity dosage and IEG effects can help 
the community better understand the dose curve of tDCS treatment. We aim to find an 
intensity that does not cause damage, but has robust changes in zif268 and cFos 
expression. Also in concurrence with the zif268 and cFos we hope to show that tDCS 
treatment can lead to changes in cortex, as well as hippocampal region. We are 














Male Sprague Dawley rats (Charles River) between 300-500 g were utilized for this 
study. Animals were quarantined for 10 days upon entry in an AAALAC (Association for 
Assessment and Accreditation of Laboratory Animals) accredited animal facility and 
were doubly housed with ad libitum access to food and water. All testing was conducted 
during the light cycle. All procedures were approved by the Wright-Patterson Air Force 
Base (WPAFB) Institutional Animal Care and Use Committee and performed in 
accordance with the National Institute of Health standards and the Guide for the Care and 
Use of Laboratory Animals (National Research Council, 2011). 
Surgeries: 
Animals underwent surgery in order to place the head electrode 2.5mm caudal bregma. 
Animals were anesthetized with isoflurane (Piramal) at an average of 2-3%. An incision 
was made to expose skull, and head electrode (approximately 25 mm2; Avelgaard 
Manufacturing Factory ltd) was placed 2.5mm caudal bregma and held in place by a head 
clamp (AFRL). C&B Metabond Adhesive Luting Cement (Parkell Inc.) was added to 
electrode and clamp, and allowed 5 minutes to dry. Acrylic (Henry Shein), was added 
over cement in order to maintain integrity of the electrode connection. Once the acrylic 
hardened, the head incision was sutured closed and animals were placed back in home 
cage. Animals recovered uneventfully at least 7 days before tDCS treatment.  
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Animals were brought into the behavioral room a couple minutes before tDCS began. 
The reference electrode was attached between shoulders with Signagel electrode gel 
(Parker Laboratories) and held in place with Petflex cohesive bandage (Andover). The 
animal was placed in a novel object arena (40.5 cm x 45 cm x 36 cm Plexiglas), with 
three novel objects. Fishing line was used to hold a washer, diameter 2.5 cm, above arena 
in order to feed reference and head electrode wires through in order to stay out of reach 
of animal. Animals were freely able to explore environment.  A resistance measure was 
taken with an impedance meter (Grasstechnologies) in order to check the status of the 
head electrode connection and if under 150 kΩ the animal would precede to tDCS 
treatment. Using a Magstim DC-stimulator (Neuroconn) tDCS treatment was applied. 
Between animals the arena was cleaned with 50% ethanol.  For anode stimulation the 
head received the negative current while the reference electrode received the positive 
current. In the sham group the electrode wires were connected to the Magstim DC-
Stimulator but no stimulation occurred. Animals received anodal (75 µA) or sham (0 µA) 
stimulation for 20 minutes, and were placed back in their home cage after treatment. For 
immunohistochemical collection, animals were euthanized immediately following 
treatment; RNA animals were euthanized 20 minutes following end of stimulation 
(Figure 2). 
In anesthetized experiments animals were brought into the procedure room and 
anesthetized with 2-3% isoflurane (Piramal). Once the animals were determined to be 
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anesthetized it was moved to a nose cone and remained under isoflurane for the entire 
procedure. For immunohistochemical animals, stimulation duration was 60 minutes 
(Figure 2) followed by euthanasia immediately upon completion of stimulations. RNA 
animal’s stimulation duration was 20 minutes and sacrifice occurred 20 minutes post-
stimulation. The current intensities applied for immunohistochemical experiments were: 
0µA, 150 µA, 300 µA , 500 µA, 1000 µA, 2,500 µA (Table 1). The current intensities 







     










Stimulation 20 minutes RNA Collection 
20 min 
Figure 2: Experimental Design. Awake animal experiments have 
same experimental design for IHC and RNA collection. Anesthetized 
animals have two experimental designs split between IHC and RNA 
collection 
Stimulation RNA Collection Awake Animals 
IHC Collection 
10 










1 Awake CON, 0µA, 75 
µA 
20 min RNA  
1 Awake CON, 0µA, 75 
µA 
20 min IHC 
2 Anesthetized 0µA, 150µA, 
300 µA 
60 min IHC 
2 Anesthetized 500µA, 250 µA 60 min IHC 
3 Anesthetized 0µA, 250µA, 
500µA, 
2,000µA 




Means of euthanasia depended on the experiment to be conducted with the tissue. All 
RNA animals were euthanized by means of rapid decapitation. Tissue was dissected and 
frozen immediately. All immunohistochemical animals were injected with  0.001-0.002% 
Table 1: Experimental outline of animal consciousness, current 
intensities, and experimental type (RNA or IHC) 
11 
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body mass of euthasol and perfused with 150-200mL 1X PBS followed by 150-200mL 
4% PFA. All euthanasia techniques were in accordance with AVMA guidelines (2013). 
 
Transcript level expression: 
After animal euthanasia, the brain was removed from the skull and sectioned on rat brain 
matrix (Zivic Instruments). After the slice was removed cortex regions and hippocampi 
were dissected, placed in an RNase free tube, and immediately put on dry ice and stored 
at -80°C. RNA extraction utilized RNeasy Mini Kit (Qiagen) following manufacturers 
protocol. For RNA quality the Nanodrop (Nanodrop 100 Spectophotometer, 
ThermoScientific) was utilized and concentration was used to normalize samples before 
cDNA synthesis. The High Capacity RNA to cDNA kit (Applied Biosystems) was used 
to synthesize 500 ng of RNA into cDNA. cDNA product was then used for quantitative 
real-time PCR (qRT-PCR, Figure 4) which was performed on StepOne Plus PCR 
Machine (Applied Biosystems) while using Fast SYBR Green Master Mix kit protocol 
(Applied Biosystems, Figure 3).  
 
12 
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The primers (Eurofins MWG Operon) used with the reaction were as follows: Hprt1 
forward 5’GACCAGTCAACGGGGGACAT 3’ and reverse  
5’GGGGCTGTACTGCTTGACCA 3’, EDA forward 5’ 
AGTAGGCGTGTTCGCCGCAA 3’ and reverse 5’ GTCCCTGGGGTCCTGGAGGT 3’,  
cFos forward 5’CAAGGACCCTGACCCCATAGT 3’ and reverse 
5’GATACGCTCCAAGCGGTAGGT 3’, and zif268 forward 
5’GAAAGCCCTTCCAGTGTGGAATCTG3’ and reverse 
5’GGAAGAGGCAGCTGAGGAGGCCAC3’. Melt curve analysis was taken into 
account (StepOne Plus, Applied Biosystems) to determine the reaction integrity. All 
reactions had a single peak in melt curves indicating a pure product. Fold changes were 
calculated using ∆∆CT  Comparative method with endogenous control value averaging CT 
values of Hprt1 and EDA . Fold changes were analyzed by a 1-way-ANOVA to 
determine group differences.   
Figure 3: Representation of chemical reaction of 
SYBR Green 1 dye with double-stranded DNA 
during PCR 
Applied Biosystems FAST SYBR Green  
13 





Validation of Primers 
Primers were designed using Primer Blast (NCBI) in which primers were chosen if they 
meet the following criteria: GC criteria below 60%, Tm temperature near 60°C, and 
primer needed to stretch across two exons. At minimum 3 primers were chosen in order 
to perform optimization experiments. First primers were run at various temperatures 
(55°C-65°C) to determine which temperature yielded the lowest Ct values indicating 
maximal performance. Next melt curves were examined to see if primers yielded one 
pure product. If the primers passed the previous criteria, then a serial dilution PCR 
experiment was run in order to determine the efficacy of the reaction. Primers were 
selected that had an efficacy values between 90-100%. 
 
 
Figure 4: Schematic of steps involved with qRT-PCR 
Applied Biosystems   
14 
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ΔΔCt Comparative Method: 
The analysis method for mRNA experiments utilized the ΔΔCt method to determine 
differences in fold changes. This method compares between endogenous control genes 
and target genes to determine the fold change difference between groups. The threshold 
value (Ct) is the value in which the reaction begins its exponential phase. Each sample 
was first normalized to their own endogenous control Ct value, which was the average of 
Hprt1 and EDA Ct values. The normalization equation is:  
∆𝐶𝑡 = 𝐶𝑡 𝑡𝑎𝑟𝑔𝑒𝑡 𝑔𝑒𝑛𝑒 − 𝐶𝑡 𝑒𝑛𝑑𝑜𝑔𝑒𝑛𝑜𝑢𝑠 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 
 This value is called the ΔCt value. The next normalization is compared against the 
average ΔCt  of the control group; in experiment one it was the cage control group and in 
experiment three it was sham.  The equation to calculate this value is: 
∆∆𝐶𝑡 =  ∆𝐶𝑡 𝑡𝑎𝑟𝑔𝑒𝑡 𝑔𝑒𝑛𝑒 (𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑔𝑟𝑜𝑢𝑝)− ∆𝐶𝑡 𝑒𝑛𝑑𝑜𝑔𝑒𝑛𝑜𝑢𝑠 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑔𝑟𝑜𝑢𝑝) 
 This accounts for the difference in ΔCt values of the target gene in both treatment and 
control groups. To calculate the fold change, we used the equation: 
𝐹𝑜𝑙𝑑 𝐶ℎ𝑎𝑛𝑔𝑒 = 2−∆∆𝐶𝑡 
Values that were more than 2 standard deviations away from the group mean were 
eliminated from further analysis. 
Melting Curve Analysis: 
To insure the integrity of the PCR reaction a melt curve analysis was run in order to 
verify the existence of one pure product. At the end of the PCR reaction all the copies of 
15 
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transcript are in double strand form, meaning SYBR is bound and there is high 
fluorescence. The melt curve takes a fluorescence measurement every 0.3°C and 
increases from 65°C to 95°C. The program indicates a melting temperature when the 
fluorescence drops suddenly, indicating the double stranded DNA has dissociated. This 
technique is standard protocol when utilizing SYBR Green fluorescent marker for qRT-
PCR reactions. 
Immunohistochemical experiments: 
Animals were perfused with ~150mL of 1 X PBS followed by ~150 mL of 4% 
paraformaldehyde (PFA). After perfusion the brain was extracted and stored in 4% PFA 
at 4° C for 24 hours. After allotted time the brain was removed from PFA solution and 
placed in a 30% sucrose solution for several days until brain ceased floating. Once the 
brain sank to the bottom of the tube it was determined to be ready to section.  Brains were 
sliced frozen at a thickness of 16 μM on Leica SM2010R Micro-tome (Leica Biosystems) 
at an average temperature of -30°C. Slices were transferred to a cyroprotectant solution 
(0.1M Na Phosphate Buffer at 7.2 pH, polyvinylpyrolidine, ethylene glycol, and sucrose) 
and stored at -20°C until needed for staining protocol. Following removal from 
cryoprotectant, sections were washed 5 times for 5 minutes in 1X Phosphate Buffer 
Saline solution (PBS). After washing the sections were blocked for 1 hour in Blocking 
Buffer (1X PBS, 100X Triton, and Goat Serum). Primary antibodies were added to the 
blocking buffer solution and incubated at 4°C overnight. Primary antibodies utilized were 
rabbit anti-zif268 (dilution 1:1,000, Santa Cruz Biotechnology), and mouse anti-NeuN 
(dilution 1:12,500, Millipore). After primary antibody incubation sections were washed 
again in 1X PBS 5 times for 5 minutes. Blocking buffer and secondary antibodies were 
16 
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added at this time and incubated in the dark at room temperature for one hour. Secondary 
antibodies utilized were Alexa-Fluor488 goat anti-rabbit (dilution 1:500, Jackson 
ImmunoResearch, Figure 6) and AlexaFluor594 goat anti-mouse (dilution 1:500, Jackson 
ImmunoResearch). Once secondary incubation was complete slices were washed again in 
1X PBS 5 times for 5 minutes. Then, a final wash was performed in 0.1M Phosphate 
Buffer (PB) for 5 minutes before sections were mounted on the slides. The mounting 
media used was Fluoromount (Sigma-Aldrich) and slides were cover slipped and sealed. 
 
Immunohistochemical Data collection 
 For hippocampal CA1, images were stitched using the pairwise stitch plugin 
provided by ImageJ35. CA1 images were manually counted by 3 scorers, in which median 
value was used. Scorers counted number of NeuN labeled cells, followed by number of 
co-localized cells indicated by yellow stain (NeuN= red and zif268= green, Figure 7).  
For the cortex regions, NeuN labeled cells were counted via ImageJ ‘Analyze Particles’ 
program. The regions of colocalization were identified utilizing the colocalization finder 
plugin for ImageJ. The percent expression of zif268 was computed by dividing the 

















                                                                             
                                                               










Experiment 1: RNA 
Figure 5: Region of interest for each 
experiment. Images provided by 
brainmaps.com. Panel A) Experiment 
One RNA experiments, Panel B) all IHC 
experiments, and Panel C) Experiment 











All statistical analysis was completed using SigmaPlot (Version 4.17) and a 1-way 
ANOVA was run to verify group differences between mRNA fold changes and protein 
expression levels. If normality failed, a ranked 1-way ANOVA was used to analyze 
results. A 2-way ANOVA was run to determine differences between brain regions and 
treatment groups. To determine whether the mRNA hippocampal data from experiment 
three could be combined, a two- tailed two- sample t-test was run to verify differences 
between groups. Significance was based off a p-value <.05. 
 
 
Figure 6: Immunohistochemistry reaction 
schematic. Example being labeling of zif268 protein. 
Alexa-Fluor 488 Goat 
anti-rabbit  
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Figure 7: Result of immunohistochemical experiments. The red cells are NeuN 
stain, green zif268 stain, and yellow is the colocalization of the two antibodies 
indicating neurons expressing zif268. Arrows indicate examples of double labeled 
cells. 
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tDCS treatment in awake animal: 
 Animals received stimulation (SHAM or 75 µA) for 20 minute duration while 
awake in novel environment. The transcript levels of cFos and zif268 were measured 
with zif268 showing an increase in transcript for both SHAM and 75 µA groups (p < 
0.05) compared to cage control animals in both hippocampus and somatosensory cortex 
regions (Figure 8). Fold change values for zif268: CON 1.04 (SE± 0.09), SHAM 2.86 
(SE±0.27) and 75 µA 3.27 (SE±0.22) in the somatosensory cortex, and for the 
hippocampus CON 1.01 (SE±0.05), SHAM 1.96 (SE±0.15) and 75 µA 2.00 (SE± 0.19); 
the fold change values decrease from somatosensory cortex to hippocampus. 




































Figure 8: A) mRNA levels in somatosensory cortex, B) 




 75 µA 
        *  *                *  * 
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Zif268 Protein Response to Multiple Current Intensities: 
Following previous experiment we questioned whether sufficient current was reaching 
the brain. We decided to run an experiment where we would try to induce lesions 
concurrently with looking at zif268 protein expression. Under anesthesia, we increased 
the current intensity to 2,500 µA to the point where we could see lesions in H&E 
staining. The nature of the lesion experiment was such that the ‘n’ was small.  
Animals received stimulation (CON, SHAM, 75 µA) for 20 minutes in conscious 
animals and in anesthetized state (SHAM, 150 µA, 300 µA, 500 µA, and 2,500 µA) for 
60 minute. The first set of animals (CON, SHAM, and 75 µA) there was no main effect 
across the CTX1 (F=  0.964, p= 0.414), CTX2 (F= 0.559, p= 0.589), CTX3 (F= 2.642, 
p= 0.120), and CA1 (F=2.220, p= 0.159) with no clear relationship among current 
intensity groups. (Figure 9). The second set of animals (SHAM, 150 µA, and 300 µA) 
showed neither significance amongst groups or main effect for all brain regions (CTX1: 
F= 2.937, p=0.119, CTX2: F= 0.558, p=0.599, CTX3: F= 0.239, p= 0.794, and CA1: 
H=0.409, p= 0.848), but showed a trend of the 150 µA group having a higher proportion 
of neurons expressing zif268 than 300 µA (Figure 10). Overall the SHAM group 
consistently showed the largest proportion of neurons expressing zif268. The third set of 
animals (500 µA and 2,500 µA) showed no significant difference between groups or a 
main effect for all brain regions (CTX1: F= 0.0106, p= 0.925, CTX2: F= 7.297, p= 
0.0704, CTX3: H= 0.000, p= 1.00, and CA1: F= 1.342, p= 0.330) (Figure 11). Overall 
the two groups showed similar expression proportions between brain regions. The trend 
observed from all the experiments is as the subsequent sets increase in current intensity, 
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there is an increase in the amount of neurons expressing zif268. Next we wanted to 
determine if we could see an effect with a similar experiment, except looking at RNA. 
 




























































































 D) CTX3 
Figure 9: Zif268 protein expression levels with varying current intensities: 0 µA and 
75 µA. Expression levels represented as % neurons expressing zif268. A) CA1 
Hippocampus, B) CTX1, C) CTX2, and D) CTX3 
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 D) CTX3 
Figure 10: Zif268 protein expression levels with varying current intensities: 0µA, 150 µA, 
and 300 µA. Expression levels represented as % neurons expressing zif268. A) CA1 
Hippocampus, B) CTX1, C) CTX2, and D) CTX3 
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Transcript Response to Multiple Current Intensities: 
 Animals received stimulation (SHAM, 250 µA, 500 µA, or 2,000 µA) for 20 
minutes under anesthesia. The transcript levels of cFos and zif268 were measured in the 
following areas: centrally located cortex (CCTX), laterally located cortex (LCTX), right 
HIP (RHIP), and left HIP (LHIP).  The largest increase in transcript fold changed was 
observed in CCTX (Figure 12) and decreased as regions moved further from CCTX. cFos 




































































































 D) CTX3 
Figure 11: Zif268 protein expression levels with varying current 
intensities: 500 µA and 2,500 µA. Expression levels represented as % 
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increase in fold change of all brain regions, cFos 13.99 (SE± 1.934) and zif268 1.633 
(SE± 0.095).  
For cFos in the CCTX there was a main effect of H= 20.04, p< 0.001, with  the 
2,000 µA group being significantly different than Sham and 250 µA groups (Q= 4.43, 
p<0.05 and Q= 2.82, p< 0.05). In the LCTX there was a main effect of H= 18.30, p< 
0.001, with the 2,000 µA and 250 µA groups significantly different than the sham, Q= 
4.20, p< 0.05 and Q= 2.49, p< 0.05, respectively. For RHIP and LHIP there was a main 
effect observed, H= 15.10, p=0.002 and H= 16.62, p< 0.001 respectively, and the 2,000 
µA group was significantly different than Sham, 500 µA, and 250 µA groups. For RHIP 
statistical values yielded, Q= 3.46, p< 0.05 (2,000 µA vs. Sham), Q= 3.20, p< 0.05 (2,000 
µA vs. 500 µA), and Q=2.79, p< 0.05 (2,000 µA vs. 250 µA). For LHIP the statistical 
values were Q= 3.50, p< 0.05 (2,000 µA vs. Sham), Q= 2.81, p< 0.05 (2,000 µA vs. 500 
µA), and Q= 3.35, p< 0.05 (2,000 µA vs. 250 µA). 
 For zif268 in the CCTX there was a main effect F= 18.37, p< 0.001 with the 
2,000µA group being significantly different than the Sham, 250 µA and 500 µA groups 
(t= 6.48, p<0.001, t=5.69, p< 0.001, and t=6.10, p< 0.001). In the LCTX there was a main 
effect of F= 6.80, p= 0.002 with the 2,000 µA group being significantly different than 
Sham, t= 3.72, p= 0.001, 250 µA, t= 3.83, p< 0.001, and 500 µA, t= 3.64, p= 0.001. For 
RHIP and LHIP there were main effects, H= 9.10, p= 0.028 and F=7.31, p= 0.001 
respectively. In the RHIP there were no significant differences between groups, but in the 
LHIP there were significant differences in which 2,000 µA group was different than 250 
µA (t= 2.83, p= 0.045) and 500 µA group (t= 4.63, p< 0.001). 
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         *#       *^ 
Figure 12: (a) cFos mRNA levels in Central Cortex, (b) zif268 mRNA levels 
in Central Cortex. *= p<0.05 vs. Sham and ^=p<0.05 vs. 250µA and 500 
µA, #= P<0.05 vs. 250 µA 
      * 
      *        *^ 
Figure 13: (a) cFos mRNA levels in Lateral Cortex, (b)zif268 mRNA 
levels in Later Cortex. *= p<0.05 vs. Sham and ^= p<0.05 vs. 250 µA 
and 500 µA.  
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Transcript changes across brain regions 
To measure changes between brain regions a 2-way ANOVA was implemented. For cFos 
a main effect was observed between brain regions yielding an F ratio of 25.52, p< 0.001 
and an interaction between Current Intensity x Brain Region was observed, F= 11.80, p< 
0.001. A post hoc test revealed fold changes in CCTX and LCTX were higher than those 
in RHIP (t= 2.83, p< 0.001 and t=2.47, p< 0.001), and LHIP (t= 3.19, p< 0.001 and 
t=2.85, p< 0.001). Within those groups results revealed that 2,000 µA group had higher 
fold change values in CCTX and LCTX than RHIP  (t= 7.60, p< 0.001 and t= 5.53, p< 


































 B) zif268 
RHIP
LHIP
Figure 14: (a) cFos mRNA levels in hippocampus, (b) zif268 mRNA 
levels in hippocampus. *= p<0.05 vs. Sham, 250 µA, and 500 µA. ^= 
p<0.05 vs. 500µA and 250 µA. 
    *   *                 ^ 
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For zif268 a main effect observed between brain region, F= 12.30, p< 0.001 and an 
interaction between Current Intensity x Brain Region F= 2.85, p= 0.002 showed 
significance. Post hoc test showed fold changes in CCTX and LCTX were higher than 
those in RHIP (t= 6.05, p<0.001 and t= 3.73, p= 0.002), and LHIP (t=4.10, p< 0.001 and 
not significant against LCTX). Post hoc test also revealed changes in mRNA of current 
intensities across brain regions. The 500µA group had higher fold change values in 
CCTX compared to RHIP (t= 3.10, p= 0.024). The 2,000 µA group showed higher fold 
change values in CCTX compared to RHIP ( t= 6.70, p< 0.001), LHIP ( t= 5.91, p< 
0.001), and LCTX ( t= 2.87, p= 0.024). 































































              *
                     * 
Figure 15: mRNA levels in all brain regions, A) cFos and 
B) zif268. *= <0.001 vs RHIP and LHIP, ^ = <0.5 vs. 
LCTX 
    *^ 
         * 
            * 
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 The aim of this study was determine whether tDCS stimulation modulates 
neuronal activation via IEG expression levels. IEG’s are ideal to study because they are 
induced with different types of stimulation33 and are markers for neuronal activation. 
This is an important topic, since prior to this cFos and zif268 have not been studied in 
rodent tDCS models. Our results show that neuronal activation and the ability to 
penetrate deeper regions is dependent on current intensity. This information is imperative 
to move forward, because we have outlined the strength of current needed to penetrate 
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zif268 CTX1 CTX2 CTX3 CA1 CCTX LCCTX RHIP LHIP 
Control vs. Sham 0.307 0.539 0.060 0.201 x x x x 
Control vs. 75 µA 0.991 0.315 0.071 0.061 x x x x 
Sham vs. 75 µA 0.238 0.638 0.912 0.414 x x x x 
Sham vs. 150 µA 0.046 0.678 0.620 -  x x x x 
Sham vs. 300 µA 0.16 0.346 0.521  - x x x x 
150 uA vs. 300 µA 0.331 0.548 0.887  - x x x x 
500 uA vs. 2500 
µA 0.925 0.074  - 0.33 x x x x 
Sham vs. 250 µA x x x x 0.805 0.968 0.213 0.774 
Sham vs. 500 µA x x x x 0.694 0.824 0.197 0.145 
Sham vs. 2000 µA x x x x <0.001 0.001 0.897 0.109 
250 uA vs. 500 µA x x x x 0.676 0.850 0.971 0.132 
250 uA vs. 2000 
µA x x x x <0.001 <0.001 0.216 0.045 
500 uA vs. 2000 
µA x x x x <0.001 0.001 0.223 <0.001 
cFos                 
Sham vs. 250 µA x x x x -   - -   - 
Sham vs. 500 µA x x x x  - -  -   - 
Sham vs. 2000 µA x x x x <0.05 <0.05 <0.05 <0.05 
250 uA vs. 500 µA x x x x  - -   -  - 
250 uA vs. 2000 
µA x x x x <0.05  - <0.05 <0.05 
500 uA vs. 2000 




Neuronal Activation and tDCS 
tDCS is thought to modulate behavioral outcomes in subjects by altering neuronal 
activation of the stimulated area and the surrounding regions28. With two polarities of 
stimulation, anodal and cathodal, the effect on neuronal activation is thought to be 
inhibitory or excitatory13. In this study we investigate whether increasing anodal current 
intensity will modulate neuronal activation via the IEG’s zif268 and cFos. Our results 
Table 2: Summary of results. Bold values indicate significance. All cFos 
experiments failed normality, so a ranked 1-way ANOVA was run. Notation of 
‘x’ indicates comparison was not part of the experiment. 
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show that tDCS alone affects IEG transcript levels, but that the highest current intensity 
of 2,000 µA, displayed the highest mRNA fold changes compared to the lower intensities 
(Table 2). Also for this same group, it consistently showed a significant increase in fold 
change for all brain regions. This indicates that at the highest current intensity, neuronal 
activation occurs in a deep region, like the hippocampus. For cFos in the CCTX mRNA 
fold changes for 2,000 µA showed a significant increase in mRNA levels compared to all 
of current intensity groups (Figure 12a). For zif268 in all brain regions, only the 2,000 
µA group showed a significant increase from sham and for CCTX and LCTX from the 
other current intensities (Figures 12b, 13b, 14b). 
 IEGs are ideal to examine neuronal activation since these genes have been 
involved in response to caffeine26, auditory cued fear conditioning27, and odor-induced 
neuronal activation23. These genes have been involved with multiple types of stimulation; 
usually involving the region associated with the stimulus22. This coincides with previous 
research looking at how transcortical direct current affects neuronal activation via 
amplitudes of evoked action potentials. Bindman showed that after 20 minute 
stimulation, there was an increase in the peak amplitude of action potentials in the 
somatosensory cortex8. Studies in humans examine motor evoked potentials (MEPs) in 
individuals following anodal stimulation, showed that anodal stimulation displayed 
higher MEP values than cathodal stimulation7; again with anodal tDCS we see an overall 
increase in activity. Since we conventionally view neuronal activation as an increase in 
stochastic firing rates4, 10, 13, our results support the electrophysiological results.  
Concurrent with previous results, our data shows increases in neuronal activation markers 
due to tDCS above the sham baseline levels.  
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Spread of tDCS current 
With this study we have shown that there is a spread of tDCS current. In 
experiment three, we examined three different brain regions: Central CTX (CCTX), 
Lateral CTX (LCTX), and Hippocampus (HIP), in which the hippocampus was split into 
right (RHIP) and left (LHIP) hemispheres. We chose these regions based off of the 
electrode placement and distance from electrode. The order of regions from closest to 
electrode site to farthest is: CCTX, LCTX, and HIP. For both cFos and zif268 in the 
2,000 µA group, CCTX and LCTX showed a significant increase in mRNA fold change 
compared to HIP (Figure 15). This indicates that as the current spread to deeper regions 
the effect it elicits is less than being closer to stimulation site. 
 When looking at zif268, other current intensity groups showed significant 
differences among brain regions. The 2,000 µA group was significantly higher than 
LCTX, RHIP, and LHIP, indicating a reduction of IEG induction as current spreads. The 
500µA group showed a significant increase in CCTX compared to RHIP. So we see the 
drop off in current not only in the highest intensity group, but the lower levels as well.  
This indicates that current intensities within our experiment range reduce their effects as 
the current moves further away from stimulation site. A trend is also observed between 
CCTX and LCTX region, where both cFos and zif268 in CCTX, showed the higher fold 
change value than LCTX. This did not reach significance for cFos, but it follows the 
pattern of decreasing fold change as the current moves from CCTX. So, not only can we 
see the pattern in the highest intensity, but that this pattern is reiterated in the lower 
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intensity groups. This evidence indicates that regardless of current intensity there is a 
drop off in effects seen as you move further away from stimulation site. 
The results indicate that as the current spreads, it loses its potential to cause IEG 
induction and this is seen in the decrease in fold changes of IEGs across brain regions. 
Other studies have modeled the spread of current in relation to human brain; and have 
shown that the strongest concentration of current is under the electrode, and dissipates as 
the current spreads across the brain28. We have demonstrated the spread of tDCS current 
by means of IEG induction, and how the spread is related to current intensity. We 
observe smaller mRNA levels in deeper brain regions, indicating there is less neuronal 
activation. 
 A threshold current (2,000 µA) needs to be reached in order to observe effects in 
HIP (changes compared to sham). The lower current intensities, 250 µA and 500 µA, did 
not show significant change from sham in the hippocampus (Figure 14); indicating by the 
time the current reached the hippocampus it was not sufficient enough to cause a change 
in IEG levels. This is an important concept to understand, since targeting deeper regions 
like the hippocampus is of interest to the research community. In order to target deeper 
regions researchers need a sufficient current intensity that not only causes neuronal 
activation but does not induce lesions. 
 
Differential IEG Expression 
This study showed that there is a differential expression of cFos and zif268 under 
the same stimulation parameters. These genes show a difference in fold changes and a 
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differential response due to stimulation environment.  In this study both of these genes 
responded to stimuli, but to different parameters. As shown in the awake animal 
experiments, zif268 showed induction in both sham and 75 µA (Figure 8), indicating this 
induction was due to novel object environment; but cFos was not induced. In the mRNA 
experiments with varying current intensity, in which the animals were anesthetized, cFos 
showed higher fold change values compared to zif268. Our results coincide with others 
about the effects of anesthesia on zif268 expression. Researchers have looked at the 
effects of tetanic stimulation under anesthesia; they reported a decrease in zif268 
expression when compared to the awake animals29. So, the effect seen in our results may 
be dampened by the use of anesthesia. 
High frequency and theta burst stimulation is known to induce LTP29, 30, 31 and 
there is a strong correlation with zif268 expression and LTP maintenance17, 31.  Our 
stimulation parameter is a constant current stimulation for 20 minutes for mRNA animals 
and 60 minutes for immunohistochemical animals. Previous results indicate that zif268 is 
highly expressed when there is LTP induction17. In case of our first experiment, in which 
awake animals were placed in a novel object arena during stimulation; this could have 
contributed to why we saw zif268 induction and not cFos. Researchers investigated 
expression levels of cFos and zif268 with TMS treatment and how it was modulated with 
different stimulation parameters9. They showed that current involving intermittent theta-
burst throughout stimulation induced the expression of zif268, but not cFos when 
compared against sham values9. With the theta burst paradigm, cFos expression was not 
significantly different from sham stimulation in somatosensory cortex9. Now, in the same 
study cFos showed strong induction with both high and low frequency current, which was 
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not the case for zif268 expression9. This indicates that cFos induction is related to 
stimulation alone, and not to LTP inducing stimulation. Interestingly, there is another 
difference between zif268 and cFos induction; dependence on NMDA channel. Evidence 
shows that zif268 is dependent on NMDA channel; in that with an addition of an NMDA 
blocker, zif268 levels dropped significantly, whereas the cFos levels were unaffected32.  
This coincides with the evidence above listing zif268 as being strongly correlated with 
LTP maintenance17, 18. The difference in stimulation type could attribute to the 
differences seen in experiment one.  
Another factor that results in the differential expression of these two IEG’s is 
auto-regulation. These two genes are different in that cFos auto- down regulates itself, 
while zif268 auto-up regulates itself15, 33. The basal expression of zif268 is higher than 
cFos, and cFos is induced at a much quicker rate, with the half-life of mRNA and 
proteins approximately 10-15 minutes24. Other studies have conducted analyses 
comparing cFos and zif268 levels, and have shown that basal levels of zif268 are larger 
than cFos, and that the fold changes observed was larger for cFos than for zif2689. The 
differences in fold changes could be related to the basal levels of zif268. This is seen with 
our raw Ct values (data not shown) in which the cFos values were consistently higher 
than the other targets, indicating a lower expression profile. The raw Ct values for zif268 
were relatively closer to the endogenous control genes.  With our evidence and other 
researcher’s findings, this indicates that cFos has low basal expression and with induction 
has a larger surge than that of zif268. This does not mean that cFos reacts more to the 
stimulation; but explains the differential expression of cFos and zif268 in our 
experiments. 
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Dose response of current intensity 
 Our results indicated there is not a linear relationship between current intensity 
and IEG induction or neuronal activation. The highest current intensity (2,000 µA) 
consistently showed higher mRNA levels for both targets, but for protein expression 
experiments with zif268 there was not a clear relationship between each of the currents 
(Figures 9,10,11). There is a trend within our sets of experiments that show; as there is an 
increase in current intensity, the percent of neurons expressing zif268 also increased. 
Although within each immunohistochemistry set, there were no significant differences 
between current intensity groups.  
These results do not differ with results seen when other groups modulate current 
intensity. It has been shown that when the current intensity was increased to 2,000 µA 
cathodal current had an excitatory effect, which is the opposite effect conventionally 
observed with cathodal stimulation25. Their data shows that when the current intensity is 
above a threshold current value, that conventional results of tDCS stimulation do not 
remain the same, meaning what is expected to be the outcome is not what occurs. A 
similar effect was observed with our mRNA and protein results. For the zif268 protein 
level expression, even though significance was not reached, the trend is not in a linear 
fashion. In some cases the higher intensity displayed lower zif268 protein levels. For 
cFos mRNA levels in the LCTX (Figure 13a), 250 µA showed a higher mRNA level than 
500 µA. This trend was still observed in the hippocampus (Figure 14a). Also, for zif268 
expression in the hippocampus, the 250 µA group also showed a larger fold change than 
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500 µA group. So, tDCS dose response does not seem to point towards a linear 
relationship between current intensity and neuronal activation.  
Another study showed a non-linear aspect of tDCS in which they increased the 
time of stimulation and amount of time between two stimulations34. It showed that by 
increasing stimulation duration from 13 minutes to 26 minutes, there was a decrease in 
MEP output following tDCS. The hypothesis being that increasing stimulation time 
would increase behavioral results; this was not the results observed34. This is similar to 
the hypotheses of our study; higher current intensities will produce higher fold changes in 
cFos and zif268. But, as seen with the results, this is not always the case.  
 We have shown that as current intensity increased it does not lead to a linear 
increase in neuronal activation. This is shown with the mRNA and protein expression 
level experiments, which show that in some regions the lower current intensity display 
higher expression levels than higher intensities. This is important since we can add to the 
understanding of dose response of tDCS, and that increasing the current may only be 
beneficial up to some point. Also we have showed that there is an IEG induction 
dependence on current intensity. Even though the relationship may not be in a linear 
fashion, this shows that with different current intensities there will be differential 
expression of neuronal activation markers 
 
Lesions and Current Intensity 
In experiment two we introduced variations in current intensity to induce lesions 
to prove that we are getting current across the brain. A parallel experiment was run to 
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examine the expression pattern of zif268 protein with the different current intensities. We 
saw a trend that as the sets of animals increased in current intensity, the percent of 
neurons expressing zif268 also increased. The H&E (Hematoxylin and Eosin) staining 
(data not shown) shows that any current intensity above 500 µA produced visible lesions. 
This data helped in determining the region of interest for experiments two and three, in 
that we now had evidence pointing towards the path of the current. Because of the nature 
of the lesion experiment, there was a small ‘n’ therefore making the criteria tighter in 
order to find significance amongst the immunohistochemistry data. 
In experiment three we saw that the 2000 µA group displayed the higher mRNA 
levels for both cFos and zif268. This current intensity is in the range of lesions, indicating 
that this high expression of the two IEG’s may be detrimental to the system. In some 
regions for cFos the only other group to show significance against sham was 250 µA. The 
lesions seen in experiment two were superficial, also indicating that the concentration of 
current was the strongest in the outer layers of the cortex. This coincides with the data in 
experiment three showing the highest mRNA levels were displayed in the CCTX. 
 
Moving Forward 
 In this study we investigated fluctuations in expression levels of two IEG’s, cFos 
and zif268, to determine how neuronal activation changes with current intensity. This 
study was limited to two genes, but with further research we want to investigate more 
gene targets. RNA sequencing allows researchers to see which pathways are involved 
within the same reaction. Instead of investigating how 2 gene transcripts fluctuate with 
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tDCS, researchers can investigate the transcriptome and see which are modulated due to 
tDCS. In order to fully understand biological processes we need a more directive way to 
pick out targets, and RNA sequencing allows for this direction.  
 Another question that arose during this project was differential expression of cFos 
and zif268. Both of these transcripts, although they are transcribed quickly, they have 
different temporal timelines to their transcription. By extending the time of tissue 
collection we could outline the temporal transcription levels of these targets to determine 
at which time they peak in expression levels. This would aid us in determining peak 
transcript changes between groups if the tissue was collected at the appropriate time to 
see the desired effect. 
 Researchers are also looking into the effects of repetitive tDCS34.  Once we have 
some more targets that are correlated with tDCS, we can view their fluctuations with 
repetitive stimulation to see if there is an adaptation to stimulation. This is imperative to 
know, since along with increasing current intensities, increasing the number of 
stimulations may also not be beneficial. 
 With this baseline study completed, we are able to spring forward from the 
existing data and monitor neuronal activation via cFos and zif268 to see how different 
paradigms of stimulation affect the system. We want to determine a stimulation paradigm 
that produces beneficial neuronal activation without causing lesions. In order to establish 
conventional stimulation parameters, we need to better understand what is most 
beneficial to the system. 
 
41 




 We have shown with this study that neuronal activation can be dependent upon 
stimulation current intensities. With this knowledge we can move forward with other 
gene targets and monitor their effects with tDCS treatment. Understanding the biological 
effects of tDCS is imperative since this treatment is utilized in human subjects. This 
study has identified targets that respond to tDCS, some are of interest to continue 
studying while modifying the stimulation paradigm. Further studies need to be conducted 



















mRNA Level Two-Tailed Two- 
Sample t-test 
Level 1 Level 2 Mean 
Dif 
Group Mean SEM Group Mean SEM DF t p 
cFos 
HIP 
                    
Sham-
RHIP 1.11 0.21 
Sham- 
LHIP 1.15 0.25 -0.05 11 -0.13 0.90 
250 µA-
RHIP 1.52 0.27 
250 µA- 
LHIP 1.31 0.19 0.21 14 0.62 0.55 
500 µA-
RHIP 1.31 0.24 
500 µA-
LHIP 1.48 0.16 -0.17 13 -0.53 0.61 
2,000 
µA-RHIP 5.15 0.73 
2,000 




RHIP 1.02 0.08 
Sham- 
LHIP 1.01 0.06 0.01 11 0.06 0.95 
250 µA-
RHIP 0.85 0.05 
250 µA- 
LHIP 0.99 0.04 -0.15 14 -2.17 0.05 
500 µA-
RHIP 0.83 0.08 
500 µA-
LHIP 0.88 0.04 -0.05 13 -0.50 0.63 
2,000 
µA-RHIP 1.01 0.03 
2,000 









Table 3: Two-tailed two sample t-test on RHIP 
and LHIP samples 
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